EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

miR ‐92a aggravates metabolic syndrome via KLF2 / miR ‐483 axis

Zhe Zhao, Chaofeng Ma, Longzhi Wang, Yuhang Xia, Jun Li, Wei Yang, Juan Pang, Hui Ding, Haifeng Wang, Liang Bai, Fenqing Shang iD, Feng Zhang

Journal of Diabetes Investigation · 2025-05 · 16 (5) · 893-906

DOI: 10.1111/jdi.14416 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes Investigation, 2025-02. Verfasst von Zhe Zhao und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Health Science Center, Xi'an Jiaotong University, Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: MicroRNAs, Metabolic Syndrome, Kruppel-Like Transcription Factors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shaanxi Province Natural Science Basic Research Program, Xi'an Health Committee Surface Cultivation Project, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To exam the role of miR‐92a/KLF2/miR‐483 in the pathogenesis of metabolic syndrome.

Methods

In this study, the serum of healthy controls and patients with metabolic syndrome were collected to detect the circulating level of miR‐92a and miR‐483. In vitro cultured HUVECs, overexpression or suppression of miR‐92a, miR‐483 or KLF2 to determine the relationship among miR‐92a, KLF2 and miR‐483. Ang II, ox‐LDL, or high glucose treatment were used to mimic the metabolic syndrome. HUVECs or HepG2 cells were treated with Telmisartan, Atorvastatin, or metformin, the miR‐483 and its target gene expression was detected. In animal experiment, ob/ob mice were chose to confirm the changes of miR‐92a, KLF2, and miR‐483.

Results

Compared with the healthy controls, the level of miR‐92a was significantly increased, while miR‐483 level was remarkably decreased in the patients with metabolic syndrome. In vitro cultured HUVECS, overexpression of miR‐92a significantly reduced the expression of miR‐483, but overexpression of miR‐483 had no effect on miR‐92a. Overexpression of KLF2 could downregulate miR‐483 level, while inhibition of KLF2 had the opposite effect. When HUVECs and HepG2 were stimulated with Ang II, ox‐LDL and high glucose, the expression of miR‐483 was significantly decreased and its target genes was increased. Anti‐miR‐92a could reverse the effect. Furthermore, Telmisartan, Atorvastatin, and Metformin significantly increased miR‐483 expression and decreased its target gene expression, which could be reversed by miR‐92a mimic. The level of miR‐92a was significantly increased in HepG2 cells, which were treated with exosomes derived from endothelial cells with miR‐92a overexpression. ob/ob mice showed the similar effects.

Conclusions

Endothelial dysfunction and fatty liver are critically involved in the pathogenesis of metabolic syndrome. MicroRNAs can mediate the cellular communication between vascular endothelial cells (ECs) and distal cell. Serum miR‐92a level was higher in metabolic syndrome patients than controls. KLF2 is the target gene of miR‐92a, which can increase the production of miR‐483, miR‐483 acts on its target genes CTGF, ET‐1, and β‐catenin to protect cell function. EC miR‐92a is secreted out of cells into the blood, circulates through the blood to the liver, and continues to exert its biological effects after being absorbed by hepatocytes. LNA‐miR‐92a administration reversed endothelial cell damage and fatty liver caused by metabolic syndrome by affecting the KLF2/miR‐483 pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsMetabolic SyndromeKruppel-Like Transcription FactorsHumansAnimalsMiceMaleFemaleHep G2 CellsHuman Umbilical Vein Endothelial CellsMiddle AgedCase-Control StudiesMice, ObeseAdultMice, Inbred C57BL

Stichwörter der Autor:innen

Metabolic syndromemiR‐483miR‐92a

Substanzen

MicroRNAsKruppel-Like Transcription FactorsKLF2 protein, humanMIRN483 microRNA, humanMIRN92 microRNA, humanMIRN192 microRNA, human

Autor:innen und Institutionen

  • School of Public Health, Health Science Center, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
  • Shaanxi Blood Center, Xi'an, Shaanxi, China.
  • Translational Medicine Centre, Xi'an Chest Hospital, Xi'an, Shaanxi, China.
  • Department of Cardiology, Xi'an Chest Hospital, Xi'an, Shaanxi, China.
  • Department of Cardiology, Xi'an No.3 Hospital, The Affiliated Hospital of Northwest University, Xi'an, Shaanxi, China.
  • Department of Laboratory, Xi'an No.3 Hospital, The Affiliated Hospital of Northwest University, Xi'an, Shaanxi, China.

ORCID-Profile: Fenqing Shang

Förderung

  • Shaanxi Province Natural Science Basic Research Program
  • Xi'an Health Committee Surface Cultivation Project
  • National Natural Science Foundation of China
  • Xi'an Chest Hospital Postdoctoral Innovation Base Foundation

Zitieren

APA

Zhao, Z., Ma, C., Wang, L., Xia, Y., Li, J., Yang, W., Pang, J., Ding, H., Wang, H., Bai, L., Shang, F., & Zhang, F. (2025). miR ‐92a aggravates metabolic syndrome via KLF2 / miR ‐483 axis. Journal of Diabetes Investigation, 16(5), 893-906. https://doi.org/10.1111/jdi.14416

Vancouver

Zhao Z, Ma C, Wang L, Xia Y, Li J, Yang W, et al. miR ‐92a aggravates metabolic syndrome via KLF2 / miR ‐483 axis. Journal of Diabetes Investigation. 2025;16(5):893-906. doi:10.1111/jdi.14416

BibTeX
@article{Zhao2025,
  author = {Zhao, Zhe and Ma, Chaofeng and Wang, Longzhi and Xia, Yuhang and Li, Jun and Yang, Wei and Pang, Juan and Ding, Hui and Wang, Haifeng and Bai, Liang and Shang, Fenqing and Zhang, Feng},
  title = {miR ‐92a aggravates metabolic syndrome via KLF2 / miR ‐483 axis},
  journal = {Journal of Diabetes Investigation},
  year = {2025},
  volume = {16},
  number = {5},
  pages = {893--906},
  doi = {10.1111/jdi.14416}
}
Kostenlos starten →